Dokumendiregister | Ravimiamet |
Viit | RST-1/3291-1 |
Registreeritud | 02.07.2025 |
Sünkroonitud | 03.07.2025 |
Liik | Sissetulev kiri |
Funktsioon | RST Ravimistatistika tegemine |
Sari | RST-1 Ravimistatistika alane kirjavahetus |
Toimik | RST-1/2025 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | SIA Merck Sharp & Dohme Latvija |
Saabumis/saatmisviis | SIA Merck Sharp & Dohme Latvija |
Vastutaja | Janne Sepp (RA, Peadirektori asetäitja valdkond, Ravimiohutuse osakond, Statistikabüroo) |
Originaal | Ava uues aknas |
Saatja: Veips, Artūrs <[email protected]>
Saatmisaeg: teisipäev, 18. märts 2025 12:34
Adressaat: Janne Sepp <[email protected]>; Dzirkale, Ieva <[email protected]>
Koopia: Muursepp, Andres <[email protected]>
Teema: MSD data request clarification
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Proprietary
Hello Janne.
I am new Data analyst for MSD Baltics, my colleague Andres Muursepp recommended that I get in touch with you regarding a report we recieve from you on quarterly basis called “EE Medicine Agency statistics”.
Could you please clarify few aspects regarding the data and its availability.
If this should be adressed to someone else, please let me know.
Best regards,
Artūrs Veips
Insight analyst Baltic region
MSD
A. Skanstes str. 50A, Riga, Latvia LV-1013
M. +371 28781254
Today MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., Rahway, NJ., U.S.A. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.msd.com
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Answers to Inquiry | 02.07.2025 | 1 | RST-1/3291-2 | Väljaminev kiri | ra | SIA Merck Sharp & Dohme Latvija |